Swipe om te navigeren naar een ander artikel
Mei Dong and Fangming Guo contributed equally to this study.
Traditionally, oestrogens were considered to be protective for the cardiovascular system for premenopausal women. Therefore, we conducted a retrospective case–control study to examine the association between endogenous oestrogens and acute myocardial infarction (AMI) risk among postmenopausal women.
A case–control study was performed among 30 primary AMI patients and 60 control subjects. Baseline characteristics data was collected and endogenous sex hormones levels were determined using chemoluminescence and radioimmunoassay methods. Conditional logistic regression models were developed with adjustment for confounders.
Compared with controls, the circulating oestrone, oestradiol, androstenedione and testosterone levels were significantly higher in AMI patients (P < 0.05) while the sex hormone binding globulin (SHBG) level was lower (P < 0.05). Spearman correlation coefficients showed oestradiol was positively correlated with body mass index (BMI) and waist-to-hip ratio (WHR) in cases, but not in controls. In univariable conditional logistic regression models, oestrone, oestradiol, testosterone, WHR, BMI, diabetes and hypertension were all found to be positively associated with AMI (P < 0.05). After adjusting for these factors, oestradiol (odds ratio (OR) = 4.75; 95 % confidence interval (CI) = 1.07–21.10; P = 0.04) and WHR (OR = 6.46; 95 % CI = 1.09–38.39; P = 0.04) continued to demonstrate strong positive associations with AMI.
A higher level of oestradiol was potentially associated with primary AMI risk among postmenopausal women.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598–603. CrossRef
Lipton JA, Can A, Akoudad S, et al. The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome. Neth Heart J. 2011;19(2):79–84. CrossRef
Breet NJ, Sluman MA, van Berkel MA, et al. Effect of gender difference on platelet reactivity. Neth Heart J. 2011;19(11):451–7. CrossRef
Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ. 1995;311(7014):1193–6. CrossRef
Haffner SM, Moss SE, Klein BE, et al. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1996;19(10):1045–50. CrossRef
Mikulec KH, Holloway L, Krasnow RE, et al. Relationship of endogenous sex hormones to coronary heart disease: a twin study. J Clin Endocrinol Metab. 2004;89(3):1240–5. CrossRef
Arnlov J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006;145(3):176–84. CrossRef
Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108(14):1688–93. CrossRef
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. The Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2007;50(22):2173–88. CrossRef
Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension. 2005;45(2):170–4. CrossRef
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–13. CrossRef
Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 2000;343(8):522–9. CrossRef
Chen Y, Zeleniuch-Jacquotte A, Arslan AA, et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis. 2011;216(2):414–9. CrossRef
Rivier C. Luteinizing-hormone-releasing hormone, gonadotropins, and gonadal steroids in stress. Ann N Y Acad Sci. 1995;771:187–91. CrossRef
Breen KM, Karsch FJ. Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level? Endocrinology. 2004;145(2):692–8. CrossRef
Aksut SV, Aksut G, Karamehmetoglu A, et al. The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction. Jpn Heart J. 1986;27(6):825–37. CrossRef
Sewdarsen M, Vythilingum S, Jialal I, et al. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men. Atherosclerosis. 1990;83(2–3):111–7. CrossRef
Wang C, Chan V, Tse TF, et al. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol (Oxf). 1978;9(3):249–53. CrossRef
Woolf PD, Hamill RW, McDonald JV, et al. Transient hypogonadotrophic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 1985;60(3):444–50. CrossRef
Smith GD, Ben Shlomo Y, Beswick A, et al. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005;112(3):332–40. CrossRef
Rosmond R, Wallerius S, Wanger P, et al. A 5-year follow-up study of disease incidence in men with an abnormal hormone pattern. J Intern Med. 2003;254(4):386–90. CrossRef
Baglietto L, English DR, Hopper JL, et al. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res Treat. 2009;115(1):171–9. CrossRef
Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf). 1978;9(1):59–66. CrossRef
Longcope C, Baker Jr R, Johnston CC. Androgen and estrogen metabolism: relationship to obesity. Metabolism. 1986;35(3):235–7. CrossRef
Hong Y, Yu B, Sherman M, et al. Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase. Mol Endocrinol. 2007;21(2):401–14. CrossRef
Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–30. CrossRef
Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007;56(4):901–11. CrossRef
Purohit A, Newman SP, Reed MJ. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res. 2002;4(2):65–9. CrossRef
Writing Group for Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33. CrossRef
- Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women
- Springer Berlin Heidelberg